CN105233088A - Medicine for treating chronic pelvic inflammatory disease - Google Patents
Medicine for treating chronic pelvic inflammatory disease Download PDFInfo
- Publication number
- CN105233088A CN105233088A CN201510791933.1A CN201510791933A CN105233088A CN 105233088 A CN105233088 A CN 105233088A CN 201510791933 A CN201510791933 A CN 201510791933A CN 105233088 A CN105233088 A CN 105233088A
- Authority
- CN
- China
- Prior art keywords
- parts
- effects
- medicine
- inflammatory disease
- pelvic inflammatory
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a medicine for treating a chronic pelvic inflammatory disease. The medicine is prepared from the following medicinal raw materials in parts by weight: 10 parts of angelica sinensis, 6 parts of ligusticum wallichii, 5 parts of radix paeoniae rubra, 8 parts of salviae miltiorrhizae, 4 parts of coix seeds, 3 parts of dahurian patrinia herb, 4 parts of peach kernels and 3 parts of Chinese violet. According to the medicine, angelica sinensis has the effects of nourishing blood and promoting blood circulation; ligusticum wallichii has the effects of promoting circulation of blood and qi; radix paeoniae rubra has the effects of clearing heat and cooling blood; salviae miltiorrhizae has the effects of promoting blood and qi circulation and removing stasis; coix seeds have the effects of strengthening spleen, excreting dampness, clearing heat and eliminating pus; dahurian patrinia herb has the effects of draining pus, dissolving carbuncle, promoting blood circulation to remove stasis; peach kernels have the effects of activating blood to remove stasis; and Chinese violet has the effects of clearing heat to remove stasis, cooling blood and diminishing swelling. The medicinal materials are combined to achieve the effects of promoting blood circulation to remove stasis, consolidating constitution, reinforcing vital essence, dispelling dampness and resolving toxins, and can be used for effectively treating the chronic pelvic inflammatory disease. Clinical experiments prove that the medicine can be used for treating the chronic pelvic inflammatory disease safely and effectively.
Description
Technical field
The present invention relates to a kind of Chinese medicine, be specifically related to a kind of medicine being used for the treatment of chronic pelvic inflammatory disease.
Background technology
Chronic pelvic inflammatory disease often fails thoroughly to treat for acute pelvic inflammatory disease, or caused by the poor course of disease delay of body, but also can die of illness without acute pelvic inflammatory disease.Its main pathology changes into connective tissue proliferation and adhesion, can show as chronic defeated ovum inflammation and hydrosalpinx, adnexitis and tubo-ovarian cyst and chronic pelvic paramitritis.
How not obvious clinical general manifestation is, and low grade fever, susceptible sometimes can be had tired, and course of disease elder can occur neurasthenia symptom.Topical manifestations is mainly lower abdomen falling inflation, pain and lumbosacral aching pain, increases the weight of after fatigue of being everlasting, sexual intercourse and before and after menstruation; Also menorrhagia, menoxenia, the symptom such as infertile can be had.Chang Chenghou position, gynecologial examination uterus, limitation of activity or adhesion are fixed.
Current doctor trained in Western medicine clinical treatment chronic pelvic inflammatory disease is based on antibacterials expectant treatment, but for a long time or repeatedly the multiple antibacterial drug therapy of conbined usage there is no significant curative effect sometimes, and exist medication lack of standardization, easily cause fastbacteria and produce and the various disadvantages such as double infection.Physiotherapy is as ultrashort wave, laser medicine ion-transmission etc.
Medical material involved in the present invention is recorded in all as seen " China's book on Chinese herbal medicine ".
Summary of the invention
The present invention aims to provide a kind of medicine being used for the treatment of chronic pelvic inflammatory disease, by selecting suitable medical material and proportioning thereof, reaches the object of safe and effective healing chronic pelvic inflammatory disease.
In order to achieve the above object, the present invention is by the following technical solutions:
Be used for the treatment of a medicine for chronic pelvic inflammatory disease, it is characterized in that, it is prepared from by the raw medicinal material of following weight proportion: Radix Angelicae Sinensis 10 parts, Rhizoma Chuanxiong 6 parts, Radix Paeoniae Rubra 5 parts, Radix Salviae Miltiorrhizae 8 parts, Semen Coicis 4 parts, Herba Patriniae 3 parts, 4 parts, Semen Persicae, Herba Violae 3 parts.
Inventor thinks, damp and hot congestion is retarded by silt, the cold and deficiency of CHONG and REN meridians causes blood room just to open, and vessels of the uterus is hollow.So cause chronic pelvic inflammatory disease.Therefore, should detoxify based on blood circulation promoting and blood stasis dispelling, vital base and primordial QI consolidating, damp eliminating when adopting Chinese traditional treatment.
The present invention uses: Chinese angelica blood supplementing is invigorated blood circulation; Rhizoma Chuanxiong blood-activating and qi-promoting; Radix Paeoniae Rubra clearing away heat and cooling blood; The blood stasis dispelling of Radix Salviae Miltiorrhizae blood-activating and qi-promoting; Row is dense for Semen Coicis spleen invigorating eliminating dampness by diuresis, heat clearing away; The evacuation of pus of Herba Patriniae eliminating carbuncle, blood circulation promoting competent silt; Semen Persicae blood circulation promoting and blood stasis dispelling; Herba Violae heat-clearing and toxic substances removing, removing heat from blood is subsided a swelling.All medicines share, and play effect of blood circulation promoting and blood stasis dispelling, vital base and primordial QI consolidating, damp eliminating removing toxic substances altogether, effectively treat chronic pelvic inflammatory disease.
Below in conjunction with clinical laboratory data, beneficial effect of the present invention is described:
1, physical data
Inventor collects undergoing chronic pelvic inflammation 80 example for 2012 altogether between year December of December ~ 2014, all from Out-patient Clinic of Department of Gynecology, be women, 25 ~ 50 years old age, the married 75 example, unmarried 5 example.The course of disease 5 months ~ 5 years.
Diagnostic criteria: adopt gynaecological examination to combine with B ultrasonic:
(1) ultrasound diagnosis: uterus rectum is recessed hydrops, attachment area is visited and sausage shape dark space or irregular dark space or abnormal echo;
(2) uterus tenderness; Side or bilateral adnexa thicken or increase thick;
(3) leucorrhea amount is many, presents purulence or yellow;
(4) there is official jargon operation history, have pelvic inflammatory disease medical history;
(5) lumbosacral aching pain, lower abdomen falling pain, and in menstruation, sexual intercourse or tired postemphasis.
Above 5 have more than 3 can determine diagnosis.
Meet above-mentioned diagnostic criteria, the women that the age is greater than 18 years old.
Exclusion standard: trimester of pregnancy, women breast-feeding their children; Merge serious cardiopulmonary hepatorenal disease person and malignant tumor person.
2, test method
The decoct that the oral the present invention of all patients obtains according to embodiment 1, every day 3 times.12 weeks courses for the treatment of.
3, criterion of therapeutical effect and therapeutic outcome
3.1 criterion of therapeutical effect
Judge according to " diagnosis of chronic pelvic inflammatory disease disease and efficacy assessment standard ".
1. cure: B ultrasonic prompting pelvic cavity image is normal, gynecologial examination attachment area without thickening, tenderness and enclosed mass, clinical symptom disappearance;
2. take a turn for the better: B ultrasonic prompting pelvic hydrops reduces, and gynecologial examination attachment area thickens, tenderness and enclosed mass phenomenon alleviate, clinical symptoms partial disappearance;
3. invalid: sign and symptom are obtained for comparatively significantly to be improved.Recovery from illness: the symptom such as abdominal pain and distension, menoxenia disappears completely, and the visible chronic pelvic inflammatory disease of row color ultrasound examination disappears substantially.
3.2 therapeutic outcome
80 routine patients cure 55 examples, and take a turn for the better 21 examples, invalid 4 examples, total effective rate 95%.There is laxativeness in treatments period 1 example, has no other obvious adverse reaction.It is safe and effective that visible the present invention is used for the treatment of chronic pelvic inflammatory disease, has the value applied.
Detailed description of the invention
In order to understand better and implement the present invention, further illustrate the present invention below in conjunction with specific embodiment.
Embodiment 1
Take: Radix Angelicae Sinensis 10 grams, Rhizoma Chuanxiong 6 grams, Radix Paeoniae Rubra 5 grams, Radix Salviae Miltiorrhizae 8 grams, Semen Coicis 4 grams, Herba Patriniae 3 grams, 4 grams, Semen Persicae, Herba Violae 3 grams; Add 8 times of water gagings, decoct 1.5 hours, filter; Filtering residue adds 6 times of water gagings, decocts 1 hour, filters; Merging filtrate, is concentrated into 120 grams, must meet the decoct of adult normal's one day consumption.
Be used for the treatment of chronic pelvic inflammatory disease.Oral, every bu morning, noon and afternoon take for three times.
Embodiment 2
Take: Radix Angelicae Sinensis 10 grams, Rhizoma Chuanxiong 6 grams, Radix Paeoniae Rubra 5 grams, Radix Salviae Miltiorrhizae 8 grams, Semen Coicis 4 grams, Herba Patriniae 3 grams, 4 grams, Semen Persicae, Herba Violae 3 grams; Add 10 times of water gagings, decoct 2 hours, filter; Filtering residue adds 8 times of water gagings, decocts 1.5 hours, filters; Merging filtrate, concentrated, dry, packaging, must meet the powder of adult normal's one day consumption.
Be used for the treatment of chronic pelvic inflammatory disease.Oral, daily once.
Embodiment 3
Take: Radix Angelicae Sinensis 10 grams, Rhizoma Chuanxiong 6 grams, Radix Paeoniae Rubra 5 grams, Radix Salviae Miltiorrhizae 8 grams, Semen Coicis 4 grams, Herba Patriniae 3 grams, 4 grams, Semen Persicae, Herba Violae 3 grams; Add 6 times of water gagings, decoct 3 times, each decoction 1 hour, merges decoction liquor, concentrated, dry, incapsulates shell, must meet the capsule of adult normal's one day consumption.
Be used for the treatment of chronic pelvic inflammatory disease.Oral, every bu is taken for twice sooner or later.
Claims (4)
1. one kind is used for the treatment of the medicine of chronic pelvic inflammatory disease, it is characterized in that, it is prepared from by the raw medicinal material of following weight proportion: Radix Angelicae Sinensis 10 parts, Rhizoma Chuanxiong 6 parts, Radix Paeoniae Rubra 5 parts, Radix Salviae Miltiorrhizae 8 parts, Semen Coicis 4 parts, Herba Patriniae 3 parts, 4 parts, Semen Persicae, Herba Violae 3 parts.
2. be used for the treatment of the medicine of chronic pelvic inflammatory disease as claimed in claim 1, it is characterized in that, its preparation method is: take: Radix Angelicae Sinensis 10 parts, Rhizoma Chuanxiong 6 parts, Radix Paeoniae Rubra 5 parts, Radix Salviae Miltiorrhizae 8 parts, Semen Coicis 4 parts, Herba Patriniae 3 parts, 4 parts, Semen Persicae, Herba Violae 3 parts; Add 8 times of water gagings, decoct 1.5 hours, filter; Filtering residue adds 6 times of water gagings, decocts 1 hour, filters; Merging filtrate, is concentrated into 120 parts, obtains decoct; Above-mentioned part all refers to weight portion.
3. be used for the treatment of the medicine of chronic pelvic inflammatory disease as claimed in claim 1, it is characterized in that, its preparation method is: take: Radix Angelicae Sinensis 10 parts, Rhizoma Chuanxiong 6 parts, Radix Paeoniae Rubra 5 parts, Radix Salviae Miltiorrhizae 8 parts, Semen Coicis 4 parts, Herba Patriniae 3 parts, 4 parts, Semen Persicae, Herba Violae 3 parts; Add 10 times of water gagings, decoct 2 hours, filter; Filtering residue adds 8 times of water gagings, decocts 1.5 hours, filters; Merging filtrate, concentrated, dry, packaging, obtains powder; Above-mentioned part all refers to weight portion.
4. be used for the treatment of the medicine of chronic pelvic inflammatory disease as claimed in claim 1, it is characterized in that, its preparation method is: take: Radix Angelicae Sinensis 10 parts, Rhizoma Chuanxiong 6 parts, Radix Paeoniae Rubra 5 parts, Radix Salviae Miltiorrhizae 8 parts, Semen Coicis 4 parts, Herba Patriniae 3 parts, 4 parts, Semen Persicae, Herba Violae 3 parts; Add 6 times of water gagings, decoct 3 times, each decoction 1 hour, merges decoction liquor, concentrated, dry, incapsulates shell, obtains capsule; Above-mentioned part all refers to weight portion.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510791933.1A CN105233088A (en) | 2015-11-17 | 2015-11-17 | Medicine for treating chronic pelvic inflammatory disease |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510791933.1A CN105233088A (en) | 2015-11-17 | 2015-11-17 | Medicine for treating chronic pelvic inflammatory disease |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105233088A true CN105233088A (en) | 2016-01-13 |
Family
ID=55031081
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510791933.1A Pending CN105233088A (en) | 2015-11-17 | 2015-11-17 | Medicine for treating chronic pelvic inflammatory disease |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105233088A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108114237A (en) * | 2017-12-31 | 2018-06-05 | 赵再绒 | A kind of Chinese medicinal formulae for treating chronic pelvic inflammatory disease and preparation method thereof |
CN110496198A (en) * | 2018-05-19 | 2019-11-26 | 陕西天地人和药业有限公司 | A kind of oral drugs for treating chronic pelvic inflammatory disease |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1237451A (en) * | 1999-04-01 | 1999-12-08 | 魏秀珍 | Enema liquor for woman pelvic inflammation |
CN102430025A (en) * | 2011-12-01 | 2012-05-02 | 吉林大学 | Medicine composition for treating pelvic inflammation and preparation method thereof |
CN103027968A (en) * | 2011-10-07 | 2013-04-10 | 雷蕾 | Preparation method of medicinal preparation for preventing and treating chronic pelvic inflammation |
CN104840884A (en) * | 2015-05-22 | 2015-08-19 | 郭立新 | Traditional Chinese medicinal preparation for treating chronic pelvic inflammatory disease |
-
2015
- 2015-11-17 CN CN201510791933.1A patent/CN105233088A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1237451A (en) * | 1999-04-01 | 1999-12-08 | 魏秀珍 | Enema liquor for woman pelvic inflammation |
CN103027968A (en) * | 2011-10-07 | 2013-04-10 | 雷蕾 | Preparation method of medicinal preparation for preventing and treating chronic pelvic inflammation |
CN102430025A (en) * | 2011-12-01 | 2012-05-02 | 吉林大学 | Medicine composition for treating pelvic inflammation and preparation method thereof |
CN104840884A (en) * | 2015-05-22 | 2015-08-19 | 郭立新 | Traditional Chinese medicinal preparation for treating chronic pelvic inflammatory disease |
Non-Patent Citations (1)
Title |
---|
朱时珍 等: "中西医结合治疗慢性盆腔炎60例疗效观察", 《济宁医学院学报》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108114237A (en) * | 2017-12-31 | 2018-06-05 | 赵再绒 | A kind of Chinese medicinal formulae for treating chronic pelvic inflammatory disease and preparation method thereof |
CN110496198A (en) * | 2018-05-19 | 2019-11-26 | 陕西天地人和药业有限公司 | A kind of oral drugs for treating chronic pelvic inflammatory disease |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102688410B (en) | Chinese medicinal composition for treating chronic pelvic inflammation | |
CN103768531B (en) | Chinese medicine composition being used for the treatment of rheumatoid arthritis and preparation method thereof | |
CN105233088A (en) | Medicine for treating chronic pelvic inflammatory disease | |
CN105497237A (en) | Traditional Chinese medicine used for treating hemorroide | |
CN102988846A (en) | Chinese materia medica preparation for curing pelvic congestion syndrome | |
CN104997907A (en) | Medicine for curing haemorrhoids | |
CN103893480A (en) | Traditional Chinese medicine preparation for treating kidney deficiency and blood stasis type oviduct obstructive infertility | |
CN104435362B (en) | A kind of Chinese medicine composition for the treatment of chronic pelvic inflammatory disease | |
CN102631633B (en) | Preparation method for traditional Chinese medicine wash lotion for treating constipation type acute lymphangitis | |
CN103550620B (en) | A kind of externally-applied medicinal composition treating rheumatalgia | |
CN102784376B (en) | Preparation method of traditional Chinese medicine for treating anorexia type acute glomerulonephritis | |
CN104784619A (en) | Traditional Chinese medicine for treating post-traumatic early limb swelling | |
CN104306898A (en) | Orally taken traditional Chinese medicine for treating hysteromyoma | |
CN102697865B (en) | Long pepper Chinese herba preparation for curing headache and preparation method | |
CN103610906A (en) | Pharmaceutical composition for treating pain from rheumatism | |
CN104740423A (en) | Traditional Chinese medicine for treating rheumatoid arthritis | |
CN103330843B (en) | Medicinal liquor for treating postpartum rheumatism | |
CN103860782A (en) | Pharmaceutical composition for treating chronic pelvic inflammation | |
CN117771316A (en) | Traditional Chinese medicine composition for moxa sticks | |
CN105288483A (en) | Drug for treatment of endometritis | |
CN103239695A (en) | Preparation method of traditional Chinese medicine for treating alcohol-related acute glomerulonephritis | |
CN108310332A (en) | A kind of Chinese medicine preparation and preparation method thereof for treating hemiplegia caused by apoplexy | |
CN110025683A (en) | A kind of drug for treating rheumatoid arthritis | |
CN105148214A (en) | Drug for treating uterine fibroids | |
CN110025682A (en) | A kind of drug for treating rheumatoid arthritis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160113 |